Cambridge Cancer Genomics

Acquired

CCG.ai empowers clinicians to make personalised treatment strategies…

Cambridge, United Kingdom · Founded 2015 · $4.5M raised

Headquarters
Cambridge
Employees
11–50
Founded
2015
Website
ccg.ai
Total Funding
$4.5M
Last Round
$4.5M Series ADec 2018
Rounds
1

About

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to info@ccg.ai

Summary

Cambridge Cancer Genomics is a Genomics company based in Cambridge, United Kingdom, founded in 2015. It has raised $4.5M in total across 1 round, most recently a $4.5M Series A round in Dec 2018. Investors include Refactor Capital, Romulus Capital and AME Cloud Ventures.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ADec 2018
$4.5M

Investors

Similar Companies